Stock Taper
SCREENER COMPARE ANY 2 STOCKS
IVVD
INVIVYD, INC.
NASDAQ
$0.96
▲ UP 7.15% (0.06)

KEY STATISTICS

Market Cap$284.15 M
52w High$3.07
52w Low$0.53
Dividend Yield—
Frequency—
P/E-3.11
Volume3.58M
Shares Out.294.61M

COMPANY

LEADERSHIP

William E. Duke Jr.
CHIEF EXECUTIVE
William E. Duke Jr.

COMPENSATION 2026

Salary$227,199
Stock Awards$0
Incentive Plan Pay$0
All Other Comp.$1,016,218
Total$1,243,417

ABOUT

SECTOR
Healthcare
WENT PUBLIC
August 6, 2021
METHOD OF GOING PUBLIC
SPAC
FULL TIME EMPLOYEES
122

PRICE TARGET

Target High$10.00
Target Low$9.00
Target Median$9.50
Target Consensus$9.50

UPCOMING EARNINGS

DateNov 5, 2026
DayThursday
Rev. Est.$15.04M
NOV
5
THU

PRICE

$0.96 ▲ UP 7.15% (+$0.06)
$0.90$0.93$0.95$0.989:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM0.96

About Invivyd, Inc.

https://www.invivyd.com ↗

Adagio Therapeutics, Inc. is a Waltham-based clinical-stage biopharma developing antibody solutions for infectious diseases, with lead candidate ADG20 in Phase 3 trials for COVID-19 prevention and treatment.

INDUSTRY

Biotechnology

A PRODUCT INVIVYD, INC. IS KNOWN FOR

VYD2311
VYD2311

VYD2311 is a Phase 3 investigational monoclonal antibody therapy, FDA Fast Track designated, developed as a vaccine-alternative for COVID-19 pre-exposure prophylaxis.

COMPETITORS

COMPETITOR
AZN COMPARE
GSK COMPARE
LLY COMPARE
REGN COMPARE
VIR COMPARE

Revenue by Products

IconPRODUCTQ3-2025Q4-2025Q1-2026Q2-2026
Product$13.13M $17.21M ▲$13.74M ▼$14.29M ▲

ETFS HOLDING THIS STOCK

ETFS HOLDING
34
LISTED HERE
8
RANKED BY POSITION SIZE
VTS.AX
0.00% · 7.8M
XSU.TO
0.01% · 5.3M
BBC
0.70% · 407.3K
RSSL
0.01% · 99.9K
SILX
0.27% · 35.0K
GERM
0.29% · 26.5K
BIB
0.01% · 10.5K
VETS
0.02% · 4.7K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
66.22%
HOLDERS
168
TOP 12 OF 168 · RANKED BY POSITION SIZE
Janus Henderson Group Plc
33.1M sh · $42.86M
Perceptive Advisors LLC
21.8M sh · $53.81M
Point72 Asset Management, L.P.
20.3M sh · $22.33M
Bvf Inc/Il
19.5M sh · $25.38M
Maverick Capital Ltd
19.0M sh · $46.86M
Ra Capital Management, L.P.
17.1M sh · $42.28M
Driehaus Capital Management LLC
13.1M sh · $32.27M
Mithril Ii Gp LP
11.2M sh · $12.37M
Saturn V Capital Management LLC
10.9M sh · $14.23M
Vanguard Group Inc
10.7M sh · $26.44M
M28 Capital Management LP
9.2M sh · $12.02M
Eventide Asset Management, LLC
9.1M sh · $11.79M

RATINGS SNAPSHOT

Overall rating: B-

DCFROEROAD/EP/EP/B
Discounted Cash Flow5
Return On Equity1
Return On Assets1
Debt To Equity4
Price To Earnings1
Price To Book3
Overall Score3

INSIDER TRADES

★
OFFICER: CHIEF SCIENTIFIC OFFICER
Allen Robert D. III
Sale · 102.0K shares
2026-08-15
★
OFFICER: CHIEF LEGAL OFFICER, SECRETARY
Andersen Jill
Purchase · 170.0K shares
2026-08-15
★
OFFICER: CHIEF LEGAL OFFICER, SECRETARY
Andersen Jill
Sale · 37.3K shares
2026-08-17
★
OFFICER: CHIEF COMMERCIAL OFFICER
Lee Timothy Edward
Sale · 22.4K shares
2026-08-17

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 2
HOLD 1
3 GRADES IN THE LAST 12 MONTHS
BTIG BUY HC Wainwright & Co. BUY D. Boral Capital HOLD

SECTORS PEERS

PEERPRICE
SLS$13.21COMPARE
OABI$4.47COMPARE
CCCC$3.85COMPARE
OBIO$5.18COMPARE
TARA$3.82COMPARE
CDXS$1.59COMPARE
IMDX$4.13COMPARE
NTHI$4.69COMPARE